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PROBLEMS OF EVALUATION IN A "BLIND" STUDY OF TRIAMCINOLONE
ACETONIDE AND HYDROCORTISONE CREAMS*
HARRY PARISER, M.D., D.Sc.(Med) AND PHILIP F. MURRAY, M.D.
This report is concerned with the problems of
evaluation which appeared during the course of
a study undertaken to determine the response in
various dermatoses to treatment with a .1 %
triameinolone acetonide cream' compared with a
1 % hydrocortisone acetate cream' and/or a
bland cream. Comparative studies of these
preparations have been the subject of other
reports and the consensus is that .1% triameino-
lone cream is either superior or at least the equal
of 1 % hydrocortisone cream applied locally
(1—4).
A double "blind" paired comparison method
was employed. Seven of the 28 cases evaluated
were hospitalized at the Veterans Hospital at
Kecoughtan, Virginia, for 1 to 3 months and the
others were followed under close outpatient ob-
servation. Creams were given to the hospital
pharmacist who removed the labels and substi-
tuted others designated as A, B, or C, with the
code known only to him. Nurses knew the oint-
ments only by letter. They applied the medica-
tions to the hospitalized patients and were in-
structed to avoid cross contamination. Thus, the
possibility of improper application of mcdica-
ments was virtually eliminated. The treatments
were applied 3 to 5 times per day and the results
were recorded by photographs. Similar studies
were vonducted with outpatients who were given
unidentified creams, the ingredients of which
were unknown to physician and patients. No
selectivity was considered in choosing outpatients
for the study other than their ability to follow
instructions explicitly.
Since the object of this study is not to add
another report on the evaluation of these drugs
but rather to point out some problems of evalua-
tion previously not reported, specific diagnostic
categories will not be listed.' With the exception
of psoriasis, only those dcrmatoscs known to be
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Hereafter designated as triamcinolone cream.
2 Hereafter designated as hydrocortisone cream.(All creams were supplied by Lederle Division,
American Cyanamid Company.)
'List available on request.
responsive to steroids locally applied were in-
cluded in the study.
Briefly, the last reported result was obviously
superior in 1 case of infantile eczema treated with
triamcinolonc cream and in 1 case of seborrhcic
dermatitis treated with hydrocortisone cream.
In these instances treatment was discontinued
after 7 and 5 days for reasons which do not per-
tain to the study. It became apparent that, if
the evaluation had been terminated after 2 weeks
of observation, 8 patients (almost ji/ of the cases)
would have shown superior healing with tn-
amcinolone cream compared with hydrocortisone
cream; but, if treatment was continued beyond
3 weeks, there was no apparent difference in
healing. Treatment for 6 of the 8 patients showing
initial superior healing with triameinolone cream
was continued under close hospital supervision
for periods of 3 weeks to 75 days. Some of the
problems encountered and results obtained are
deemed to be of sufficient interest to be discussed
and to be illustrated photographically.
Problem 1
A comparative evaluation of the two drugs was
attempted by treating a 4 year old single lesion
of eczematoid dermatitis of the entire lower
third of the leg with both creams, the inner
aspect with triameinolone cream and the outer
with hydroeortisone cream. No attempt was
made to restrict the patient's activity. Fig. 1
(a and b) shows the lesion before treatment;
Fig. 2 (a, b and c) shows it 11 days later at which
time the inner aspect of the lesion treated with
tniameinolone cream shows obvious healing com-
pared with the outer aspect of the lesion treated
with hydroeortisone cream. Fig. 3 shows the
entire lesion 28 days later almost completely
healed with residual hyperpigmentation.
Several interpretations present themselves:
1) triameinolone cream is superior since it healed
its side of the lesion more rapidly; 2) both are
equally effective but hydrocortisone cream acted
more slowly; 3) hydroeortisone cream really was
ineffective; and, by the time its effect (if any)
was apparent, the lesion underwent spontaneous
involution.
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Problem 2
A patient with atopie dermatitis of 20 years'
duration presented a second problem for evalua-
tion. Fig. 4a shows the eruption before treatment.
During one exacerbation, triamcinolonc cream
shows definite superiority over hydrocortisonc
cream, both applied 3 times daily, after 10 days
of treatment (Fig. 4b). When the medications
were deliberately discontinued to permit exacer-
bation (Fig. Sn), a second paired blind trial on
the same person failed to produce any significant
healing, either with triamcinolonc or hydrocorti-
sonc creams, even though the medications were
used for 28 days every 3 hours for S applications
per day (Fig. Sb).
Why did triamcinolone cream work the first
time but not the second, even with intensifica-
tion of treatment? Other controllable factors
(diet, environment, season, etc.) were identical
during both courses of treatment since the pa-
tient was hospitalized for the entire observation
period. Did this patient develop "resistance" to
local steroid therapy or was the rebound phe-
nomenon so marked that local therapy was
inadequate no matter how intensive? The pa-
tient subsequently responded to systemic
steroids.
Problem 3
A third problem for evaluation is illustrated by
a case of bilateral cczematoid dermatitis of the
lower extremities of 6 years' duration (Fig. 6a).
After 10 days of treatment 3 times daily, the side
treated with trinmcinolonc cream showed supe-
rior results compared to that treated with hydro-
cortisone (Fig. 6b). 'wVith exactly the same
schedule of treatment the side treated with
triamcinolonc cream flared by the 34th day, and
the side treated with hydrocortisone cream
showed partial involution and superior healing
compared with the side treated with triamcino-
lone cream (Fig. 6c). By the 62nd day of treat-
ment in the hospital, both legs showed equal and
almost complete healing except for residual
hyperpigmentntion (Fig. 7).
Which cream is superior? Why did the lesions
heal and then flare with no interruption or change
in treatment? Did either cream help? Was the
final result due to hospitalization or spontaneous
involution and unrelated to either mcdicament?
These variations in response and the possibility
of flare of apparently inactive lesions during
treatment under controlled circumstances are of
clinical interest.
SUMMARY AND CONCLUSIONS
1. A double blind controlled study of the effect
of .1 % triamcinolone cream versus 1 % hydro-
cortisone cream in paired dcrmatologic lesions
known to be responsive to local steroid therapy
indicated that in one-third of the patients there
was more rapid involution of the lesion(s) treated
with triamcinolone cream than the paired lesion
treated with hydrocortisone cream at the end of
two weeks. However, this difference was largely
eliminated if treatment was continued beyond
three weeks. Evaluation based on short observa-
tional periods may thus give erroneous impres-
sions of ultimate therapeutic effectiveness.
2. Several cases are discussed and demon-
strated photographically in detail to indicate
some of the difficulties of evaluation which
appeared in this type of study and in no way is
intended to disparage the method which is well
recognized as the best means of evaluating local
treatment (5—7).
3. Under controlled circumstances it has been
demonstrated that response to treatment with
steroids applied locally is not always consistent.
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